Immunosuppressive Antigen-Specific Chimeric Antigen Receptor Treg Cells for Prevention and/or Treatment of Autoimmune and Alloimmune Disorders
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- THE UNIVERSITY OF TOLEDO, Toledo, Ohio has been assigned a patent (No. US 12144829 B2, initially filed Aug. 23, 2023) developed by Juan Carlos Jaume, Toledo, Ohio, and Shahnawaz Imam, Toledo, Ohio, for "Immunosuppressive antigen-specific chimeric antigen receptor Treg cells for prevention and/or treatment of autoimmune and alloimmune disorders." . . .